A detailed history of Ostrum Asset Management transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Ostrum Asset Management holds 6,905 shares of TMO stock, worth $3.63 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
6,905
Previous 11,159 38.12%
Holding current value
$3.63 Million
Previous $6.17 Billion 30.78%
% of portfolio
0.35%
Previous 0.54%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$531.86 - $624.21 $2.26 Million - $2.66 Million
-4,254 Reduced 38.12%
6,905 $4.27 Billion
Q2 2024

Aug 13, 2024

SELL
$541.52 - $599.02 $591,881 - $654,728
-1,093 Reduced 8.92%
11,159 $6.17 Billion
Q1 2024

May 13, 2024

SELL
$528.82 - $599.43 $116,869 - $132,474
-221 Reduced 1.77%
12,252 $7.12 Billion
Q4 2023

Feb 13, 2024

SELL
$431.41 - $532.94 $1.72 Million - $2.13 Million
-3,996 Reduced 24.26%
12,473 $6.62 Billion
Q3 2023

Nov 14, 2023

SELL
$498.29 - $574.41 $393,649 - $453,783
-790 Reduced 4.58%
16,469 $8.34 Billion
Q2 2023

Aug 11, 2023

BUY
$508.46 - $591.13 $297,449 - $345,811
585 Added 3.51%
17,259 $9 Billion
Q1 2023

May 12, 2023

BUY
$535.0 - $604.82 $8.92 Million - $10.1 Million
16,674 New
16,674 $9.61 Billion
Q3 2019

Nov 13, 2019

SELL
$268.46 - $305.43 $6.24 Million - $7.1 Million
-23,250 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$257.51 - $295.55 $1.75 Million - $2.01 Million
6,810 Added 41.42%
23,250 $6.83 Million
Q1 2019

May 15, 2019

BUY
$212.17 - $273.72 $422,218 - $544,702
1,990 Added 13.77%
16,440 $4.5 Million
Q4 2018

Feb 14, 2019

BUY
$208.47 - $251.98 $3.01 Million - $3.64 Million
14,450 New
14,450 $3.23 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $206B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Ostrum Asset Management Portfolio

Follow Ostrum Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ostrum Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Ostrum Asset Management with notifications on news.